APA

Kurek K. C., Del Mare S., Salah Z., Abdeen S., Sadiq H., Lee S., Gaudio E., Zanesi N., Jones K. B., DeYoung B., Amir G., Gebhardt M., Warman M., Stein G. S., Stein J. L., Lian J. B. & Aqeilan R. I. (20100809). Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. : Cancer research.

Chicago

Kurek Kyle C, Del Mare Sara, Salah Zaidoun, Abdeen Suhaib, Sadiq Hussain, Lee Suk-Hee, Gaudio Eugenio, Zanesi Nicola, Jones Kevin B, DeYoung Barry, Amir Gail, Gebhardt Mark, Warman Matthew, Stein Gary S, Stein Janet L, Lian Jane B and Aqeilan Rami I. 20100809. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. : Cancer research.

Harvard

Kurek K. C., Del Mare S., Salah Z., Abdeen S., Sadiq H., Lee S., Gaudio E., Zanesi N., Jones K. B., DeYoung B., Amir G., Gebhardt M., Warman M., Stein G. S., Stein J. L., Lian J. B. and Aqeilan R. I. (20100809). Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. : Cancer research.

MLA

Kurek Kyle C, Del Mare Sara, Salah Zaidoun, Abdeen Suhaib, Sadiq Hussain, Lee Suk-Hee, Gaudio Eugenio, Zanesi Nicola, Jones Kevin B, DeYoung Barry, Amir Gail, Gebhardt Mark, Warman Matthew, Stein Gary S, Stein Janet L, Lian Jane B and Aqeilan Rami I. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression. : Cancer research. 20100809.